Echo IQ reviews regulatory options after FDA non-substantially equivalent 510(k)
Echo IQ (EIQ) is reviewing its regulatory options after the FDA issued a not substantially equivalent determination for its initial EchoSolv HF 510(k) application. The product is not cleared for commercial use at this time.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.